Ahead of adcomm, FDA raises safety questions for AstraZeneca’s reversal agent for life-threatening bleeds

The FDA on Thursday will convene an advisory committee to discuss the safety and efficacy of AstraZeneca’s Andexxa, which won accelerated approval in 2018 to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Events

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

November 19, 2023

Annual General Meeting of MEDICLIN AG approves all proposed resolutions – Biotech Investments

EQS-News: MEDICLIN AG / Key word(s): AGM/EGM MEDICLIN: Annual General Meeting of MEDICLIN AG approves all proposed resolutions 10.06.2024 / 09:48 CET/CEST The issuer is

June 11, 2024

Exploring mouse models for studying liver fibrosis regression

Liver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be caused by a variety of factors, including

November 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.